[{"id":12130,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/advanced-biodesign\/","name":"advanced-biodesign","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/ADVANCED-BIODESIGN-1.png","alt":""},"title":"ADVANCED BIODESIGN","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 20:01:31","modifiedDate":"2024-12-05 16:44:16","modifiedDateGMT":"2024-12-05 15:44:16","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":5,"sec":1},"status":"publish","excerpt":"Founded by Ismail Ceylan in 2010, ABD is a groundbreaking biotech company with a strong leadership team"},{"id":11892,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/aenitis-technologies\/","name":"aenitis-technologies","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-GALIEN-HLTH-2024-10.png","alt":""},"title":"Aenitis Technologies","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 14, 2024","dateGMT":"2024-11-14 20:08:23","modifiedDate":"2024-11-26 22:46:51","modifiedDateGMT":"2024-11-26 21:46:51","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":16},"status":"publish","excerpt":"Aenitis develops innovative, cost-effective acoustic\u2019s-based cell handling bioprocessing systems dedicated for cell sorting, cell washing, cell\u2019s confinement and rare cells isolation."},{"id":11895,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/ai-stroke\/","name":"ai-stroke","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/AI-Stroke-1.png","alt":""},"title":"AI-Stroke","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 14, 2024","dateGMT":"2024-11-14 20:59:33","modifiedDate":"2024-11-26 15:35:57","modifiedDateGMT":"2024-11-26 14:35:57","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":33},"status":"publish","excerpt":"AI-Stroke is revolutionizing stroke diagnostics with an AI-powered digital neurologist, designed to improve pre-hospital diagnostics. Stroke is the 2nd leading cause of death and disability worldwide, yet less than 5% of acute stroke patients receive effective treatment in time. AI Stroke has created the biggest video dataset of stroke patients in the world to train their AI, and they will provide this AI neurologist to skilled nursing facilities and EMS providers such as 911 call centers, ambulances, and ERs, targeting a 50% reduction in missed or misdiagnosed stroke cases."},{"id":11903,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/apmonia-therapeutics\/","name":"apmonia-therapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-GALIEN-HLTH-2024-11.png","alt":""},"title":"Apmonia Therapeutics","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 14, 2024","dateGMT":"2024-11-14 21:17:58","modifiedDate":"2024-11-26 20:03:49","modifiedDateGMT":"2024-11-26 19:03:49","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":52},"status":"publish","excerpt":"Apmonia Therapeutics is a biotechnology company dedicated to developing therapeutic strategies towards cancer. They are developing a first-in-class pipeline of next-generation peptide-based therapies targeting the tumor microenvironment to improve the lives of patients with cancer."},{"id":11920,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/aviwell\/","name":"aviwell","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Aviwell-1.png","alt":""},"title":"Aviwell","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 14, 2024","dateGMT":"2024-11-14 21:46:56","modifiedDate":"2024-11-26 20:12:20","modifiedDateGMT":"2024-11-26 19:12:20","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":42},"status":"publish","excerpt":"Aviwell is pioneering a revolutionary approach to feed additives that offers direct benefits to livestock producers. Aviwell addresses the inefficiencies in livestock production by harnessing the natural diversity of the gut microbiome. This cutting-edge approach aligns with consumer demand for organic, sustainable products. Built on its proprietary AI\/ML platform, Aneto\u2122, Aviwell\u2019s natural, sustainable feed solutions are designed to significantly improve animal health and production efficiency, delivering measurable gains to producer operations."},{"id":11899,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/biper-therapeutics\/","name":"biper-therapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Original.png","alt":""},"title":"BiPER Therapeutics","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 14, 2024","dateGMT":"2024-11-14 21:07:25","modifiedDate":"2024-11-25 15:45:02","modifiedDateGMT":"2024-11-25 14:45:02","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":9},"status":"publish","excerpt":"BiPER Therapeutics develop first-in-class therapeutics pushing tumors to burn out, a unique approach and a new way to treat cancers. Their first clinical candidate, BPR001-615 is at 9 months from the clinic to treat gastro-intestinal cancers"},{"id":11972,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/boydsense\/","name":"boydsense","thumbnail":{"url":false,"alt":false},"title":"BOYDSense","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 15, 2024","dateGMT":"2024-11-15 19:06:09","modifiedDate":"2024-12-05 21:15:37","modifiedDateGMT":"2024-12-05 20:15:37","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":7},"status":"publish","excerpt":"BOYDSense, an award-winning startup with R&D in France and the U.S., is a pioneer in the development of non-invasive breath analysis solutions for the risk stratification, detection and monitoring of different biomarkers.\nThe device detects the type and concentration of volatile organic compounds in exhaled breath. Their first application will be in Diabetes to replace the invasive glucose monitoring device followed by a device to risk stratify a Sepsis and the fat liver disease."},{"id":11965,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/braintale\/","name":"braintale","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-BIO-2024-Entreprises-5.png","alt":""},"title":"BrainTale","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 15, 2024","dateGMT":"2024-11-15 18:36:34","modifiedDate":"2024-11-25 15:37:12","modifiedDateGMT":"2024-11-25 14:37:12","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":42},"status":"publish","excerpt":"As many drug development programs in CNS fail due to the lack of relevant biomarkers to select patient populations and measure treatment efficacy, BrainTale offers a robust platform of brain biomarkers. Based on diffusion MRI, BrainTale biomarkers enable the quantification of diffuse brain white matter alterations, which are highly sensitive to disease progression, specific to demyelinating, neurodegenerative and neuroinflammatory processes, and easily accessible through our digital platform"},{"id":12159,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/brenus-pharma\/","name":"brenus-pharma","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Brenus-1.png","alt":""},"title":"Brenus Pharma","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 18:18:52","modifiedDate":"2024-12-18 17:49:50","modifiedDateGMT":"2024-12-18 16:49:50","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":3},"status":"publish","excerpt":"Brenus Pharma is a French pioneering biotech with the mission to prevent cancer recurrence, the main challenge in solid tumors that causes 10M fatalities each year worldwide."},{"id":11982,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/cilcare\/","name":"cilcare","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-JPM-2025-2.png","alt":""},"title":"Cilcare","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 15, 2024","dateGMT":"2024-11-15 19:21:00","modifiedDate":"2024-11-27 16:26:20","modifiedDateGMT":"2024-11-27 15:26:20","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":44},"status":"publish","excerpt":"Cilcare is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment."},{"id":12648,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/dolinnov\/","name":"dolinnov","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/12\/Dolinnov.png","alt":""},"title":"Dolinnov","author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 3, 2024","dateGMT":"2024-12-03 20:09:25","modifiedDate":"2024-12-03 23:02:00","modifiedDateGMT":"2024-12-03 22:02:00","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":40},"status":"publish","excerpt":"Dolinnov aims to develop an innovative therapeutic approach based on antisense technology to treat chronic pain, particularly neuropathic and inflammatory pain. The company specifically targets a novel therapeutic target within the peripheral nervous system, concentrating on the dorsal root ganglia (DRG)."},{"id":12331,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/emobot-2\/","name":"emobot-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Emobot.png","alt":""},"title":"EMOBOT","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 19, 2024","dateGMT":"2024-11-19 22:04:22","modifiedDate":"2024-12-06 21:33:29","modifiedDateGMT":"2024-12-06 20:33:29","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":6},"status":"publish","excerpt":"EMOBOT, a French based MedTech startup that develops an continuous Clinical Endpoint as a novel Gold Standard and a Digital Therapeutics for mood disorders."},{"id":12007,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/h-a-c-pharma\/","name":"h-a-c-pharma","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/HAC-Pharma-2.png","alt":""},"title":"H.A.C. Pharma","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 15, 2024","dateGMT":"2024-11-15 19:52:35","modifiedDate":"2024-12-09 18:10:19","modifiedDateGMT":"2024-12-09 17:10:19","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/pharma\/\" rel=\"category tag\">Pharma<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":5},"status":"publish","excerpt":"European specialty pharma delivering high therapeutic value medicines to patients. Since 2007, H.A.C. Pharma is delivering mature and innovative high value drugs to patients through distribution, in-licensing and acquisition deals"},{"id":12166,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/implicity\/","name":"implicity","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Implicity-1.png","alt":""},"title":"Implicity","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 18:24:55","modifiedDate":"2024-12-04 23:29:18","modifiedDateGMT":"2024-12-04 22:29:18","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":48},"status":"publish","excerpt":"Implicity is a global remote monitoring company specialised in cardiology."},{"id":12428,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/inflectis-bioscience\/","name":"inflectis-bioscience","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-JPM-2025-18.png","alt":""},"title":"InFlectis BioScience","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 21, 2024","dateGMT":"2024-11-21 19:07:48","modifiedDate":"2024-12-04 23:31:30","modifiedDateGMT":"2024-12-04 22:31:30","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":59},"status":"publish","excerpt":"InFlectis Bioscience is developing first-in-class therapies for neuromuscular diseases and is currently evaluating in clinic an orally available small molecule, named IFB-088 (icerguastat) that has the potential to extend lives or improve the quality-of-life for people suffering from Amyotrophic Lateral Sclerosis (ongoing phase II clinical trial) and demyelinating diseases like Charcot-Marie-Tooth disease (phase 2 ready package)."},{"id":12182,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/kifik-medical\/","name":"kifik-medical","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Kifik.png","alt":""},"title":"Kifik Medical","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 18:46:38","modifiedDate":"2024-12-04 23:33:48","modifiedDateGMT":"2024-12-04 22:33:48","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":31},"status":"publish","excerpt":"Kifik Medical is a dedicated Medical Device company focusing on developing innovative devices in various fields."},{"id":12650,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/klava-2\/","name":"klava-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/12\/Klava.png","alt":""},"title":"Klava","author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 3, 2024","dateGMT":"2024-12-03 20:21:19","modifiedDate":"2024-12-03 23:02:21","modifiedDateGMT":"2024-12-03 22:02:21","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":48},"status":"publish","excerpt":"The KLAVA laboratory develops digital medical devices (DTx), downloadable onto smartphones. The solutions are sold by prescription in pharmacies. They are recommended to assist in the process of addictions, notably sugar and tobacco."},{"id":11907,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/lys-therapeutics\/","name":"lys-therapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Lys-Therapeutics.png","alt":""},"title":"Lys Therapeutics","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 14, 2024","dateGMT":"2024-11-14 21:23:46","modifiedDate":"2024-12-09 15:22:19","modifiedDateGMT":"2024-12-09 14:22:19","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":2},"status":"publish","excerpt":"Lys Therapeutics is a pioneering biotechnology company revolutionizing the treatment of patients with neurodegenerative or neurovascular diseases by targeting blood-brain barrier (BBB) dysfunctions."},{"id":11911,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/medjeduse\/","name":"medjeduse","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-GALIEN-HLTH-2024-12.png","alt":""},"title":"MEDJEDUSE","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 14, 2024","dateGMT":"2024-11-14 21:33:33","modifiedDate":"2024-11-27 18:05:28","modifiedDateGMT":"2024-11-27 17:05:28","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":44},"status":"publish","excerpt":"MEDJEDUSE is a French company, involved in the development of regenerative medicine for the central nervous system with applications for Spinal Cord Injury, Traumatic Brain Injury and Stroke"},{"id":11924,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/netri\/","name":"netri","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Netri.png","alt":""},"title":"NETRI","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 14, 2024","dateGMT":"2024-11-14 21:57:32","modifiedDate":"2024-12-09 20:52:24","modifiedDateGMT":"2024-12-09 19:52:24","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":57},"status":"publish","excerpt":"NETRI offers the healthcare industry the possibility of generating innervated human organs which, when combined with AI algorithms, can be used to predict the clinical outcome of a drug candidate. NETRI supports pharmaceutical industries by providing predictive answers on toxicity, efficacy and modes of action for IND submissions. NETRI\u2019s platform current targets are pain management for oncology (CIPN), vaccins (dose response for skin\/intramuscular injection) and emetic response (esophagus); neurotoxicology for chemical safety of small molecules and neurological disorders (Alzheimer\u2019s, Parkinson, ALS, multiple sclerosis)."},{"id":12638,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/novalix\/","name":"novalix","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/12\/Novalix-1.png","alt":""},"title":"Novalix","author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 3, 2024","dateGMT":"2024-12-03 19:50:53","modifiedDate":"2024-12-13 19:55:24","modifiedDateGMT":"2024-12-13 18:55:24","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/cro-cdmo\/\" rel=\"category tag\">CRO & CDMO<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/cro-cdmo\/\" rel=\"category tag\">CRO & CDMO<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":11},"status":"publish","excerpt":"Novalix is a premier contract research organization, dedicated to improving the critical early stages of drug discovery by combining exceptional scientific talent and exclusive technology with a comprehensive portfolio of world-class chemistry, biophysics and pharmacology capabilities."},{"id":11932,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/okomera\/","name":"okomera","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Okomera.png","alt":""},"title":"Okomera","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 15, 2024","dateGMT":"2024-11-15 15:12:39","modifiedDate":"2024-12-04 22:57:44","modifiedDateGMT":"2024-12-04 21:57:44","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":29},"status":"publish","excerpt":"Based in France and the United States, Okomera is a pioneering biotech startup transforming drug discovery with advanced microfluidic technology and AI. Okomera\u2019s miniaturized, automated platform tests the effects of various therapeutic candidates on tumoroids derived from patient microbiopsies."},{"id":11884,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/oncodesign-precision-medicine\/","name":"oncodesign-precision-medicine","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/OPM.png","alt":""},"title":"Oncodesign Precision Medicine","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 14, 2024","dateGMT":"2024-11-14 19:39:57","modifiedDate":"2024-12-13 19:59:38","modifiedDateGMT":"2024-12-13 18:59:38","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":0},"status":"publish","excerpt":"Oncodesign Precision Medicine (OPM), founded in 2022, is a biopharmaceutical company specializing in precision medicine, dedicated to the discovery of treatments for resistant and metastatic cancers."},{"id":12432,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/pepkon\/","name":"pepkon","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-JPM-2025-19.png","alt":""},"title":"PepKon","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 21, 2024","dateGMT":"2024-11-21 19:26:16","modifiedDate":"2024-11-26 21:29:10","modifiedDateGMT":"2024-11-26 20:29:10","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":58},"status":"publish","excerpt":"PepKon is a French biotech start-up developing first-in-class therapeutic peptides for refractory or incurable cancers. Leveraging ten years of academic research, its lead candidate is a CD47 agonist derived from thrombospondin-1. It acts through a novel, calcium-dependent and selective mechanism of action that kills cancer cells while sparing healthy ones."},{"id":12141,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/poppins\/","name":"poppins","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-JPM-2025-4.png","alt":""},"title":"Poppins","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 16:23:20","modifiedDate":"2024-11-26 20:33:07","modifiedDateGMT":"2024-11-26 19:33:07","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":2,"sec":4},"status":"publish","excerpt":"Poppins has developed an innovative digital therapeutic solution for children with Specific Learning Disorders (SLD). The company\u2019s flagship product is a CE-marked digital medical device designed to improve reading abilities in children aged 7-11 with dyslexia."},{"id":11936,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/qubit-pharmaceuticals\/","name":"qubit-pharmaceuticals","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-BIO-2024-Entreprises-3.png","alt":""},"title":"Qubit Pharmaceuticals","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 15, 2024","dateGMT":"2024-11-15 15:45:20","modifiedDate":"2024-11-21 17:26:06","modifiedDateGMT":"2024-11-21 16:26:06","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":54},"status":"publish","excerpt":"Qubit Pharmaceuticals is a pioneering deep-tech company specializing in the discovery and design of novel drug candidates for complex targets, by leveraging cutting-edge molecular simulation technologies, hybrid High-Performance Computing (HPC), and Artificial Intelligence (AI). Qubit Pharmaceuticals stands at the forefront of innovation in pharmaceutical research with their groundbreaking research in quantum computing applied to quantum chemistry that promises to revolutionize drug discovery, offering unprecedented precision and speed into identifying targets, discovering novel molecules and predicting their interactions."},{"id":12146,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/spartacus-biomed\/","name":"spartacus-biomed","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-JPM-2025-6.png","alt":""},"title":"Spartacus-Biomed","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 16:50:06","modifiedDate":"2024-11-26 20:35:21","modifiedDateGMT":"2024-11-26 19:35:21","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":2,"sec":37},"status":"publish","excerpt":"Spartacus-Biomed is a French ISO13485-compliant innovative company, winner of several grants from the Occitanie region and the French state, focused on developing advanced diagnostic and therapeutic solutions for complex medical conditions."},{"id":11862,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/stromacare\/","name":"stromacare","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-GALIEN-HLTH-2024-6.png","alt":""},"title":"StromaCare","author":{"name":"admin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/admin\/"},"date":"Nov 14, 2024","dateGMT":"2024-11-14 19:19:06","modifiedDate":"2024-12-04 23:02:26","modifiedDateGMT":"2024-12-04 22:02:26","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":36},"status":"publish","excerpt":"STROMACARE aims to develop therapeutics that make the stroma 'permeable' to immune cells and other molecules of interest, to eliminate the cancer."},{"id":11969,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/surge\/","name":"surge","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Surge.png","alt":""},"title":"Surge","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 15, 2024","dateGMT":"2024-11-15 18:43:41","modifiedDate":"2024-11-26 20:15:36","modifiedDateGMT":"2024-11-26 19:15:36","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":40},"status":"publish","excerpt":"Founded with the goal of revolutionizing precision medicine, Surge is an innovative company specializing in in-depth understanding of the immune system using Al. Leveraging significant technological advancements and a team of top-tier researchers, Surge is committed to creating innovative solutions that will shape the future of personalized medicine."},{"id":12187,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/torskal\/","name":"torskal","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-JPM-2025-16.png","alt":""},"title":"Torskal","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 19:44:54","modifiedDate":"2024-11-27 17:28:14","modifiedDateGMT":"2024-11-27 16:28:14","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":24},"status":"publish","excerpt":"TORSKAL is an international biotech\/medtech company and a pioneer in green nanotechnology. The company designs gold nanoparticles for cancer treatment using green chemistry"},{"id":12154,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/tribun-health\/","name":"tribun-health","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Tribun-1.png","alt":""},"title":"TRIBUN HEALTH","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 17:42:13","modifiedDate":"2024-11-27 18:03:46","modifiedDateGMT":"2024-11-27 17:03:46","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":2,"sec":47},"status":"publish","excerpt":"Tribun Health is a leader in digital pathology solutions, revolutionizing cancer care through cutting-edge technology."},{"id":12173,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/emobot\/","name":"emobot","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Logos-site-JPM-2025-14.png","alt":""},"title":"VCLS","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 18:33:46","modifiedDate":"2024-11-27 17:39:12","modifiedDateGMT":"2024-11-27 16:39:12","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/consultant-service-firm\/\" rel=\"category tag\">Consultant\/service firm<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/other\/\" rel=\"category tag\">Other<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/consultant-service-firm\/\" rel=\"category tag\">Consultant\/service firm<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/other\/\" rel=\"category tag\">Other<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":31},"status":"publish","excerpt":"VCLS supports life science companies and engages in communication with regulators and payers."},{"id":12136,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/whitelab-genomics\/","name":"whitelab-genomics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2024\/11\/Whitelab-Genomics-1.png","alt":""},"title":"WhiteLab Genomics","author":{"name":"cmarchandin","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/cmarchandin\/"},"date":"Nov 18, 2024","dateGMT":"2024-11-18 16:04:59","modifiedDate":"2024-11-27 18:03:27","modifiedDateGMT":"2024-11-27 17:03:27","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/other\/\" rel=\"category tag\">Other<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/other\/\" rel=\"category tag\">Other<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":2,"sec":35},"status":"publish","excerpt":"Founded in 2019, backed by Y-Combinator, WhiteLab Genomics stands at the convergence of computer sciences and biology, pioneering the accelerated development of genomic medicines."}]